525 results on '"Panoulas, Vasileios F."'
Search Results
2. Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial
3. Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support: A Practical Approach
4. Predictors of left ventricular ejection fraction in high-risk percutaneous coronary interventions
5. Cardiac Catheterization
6. Fractional Flow Reserve
7. Pocket-Size Hand-Held Echocardiography
8. Female-specific survival advantage from transcatheter aortic valve implantation over surgical aortic valve replacement: Meta-analysis of the gender subgroups of randomised controlled trials including 3758 patients
9. Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions
10. In-Stent Restenosis with a Twist
11. Same IVUS, Same Vessel, Different FFR
12. A Wire in Jail
13. FFR to Determine Stent Length: When the Play Gets Tough
14. Clinical Outcomes After Implantation of Overlapping Bioresorbable Scaffolds vs New Generation Everolimus Eluting Stents
15. Sequential Lesions and Bioresorbable Scaffolds
16. Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience
17. Influence of baseline ejection fraction on the prognostic value of paravalvular leak after transcatheter aortic valve implantation
18. Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent
19. A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study
20. Procedural Feasibility and Clinical Outcomes in Propensity-Matched Patients Treated With Bioresorbable Scaffolds vs New-Generation Drug-Eluting Stents
21. The role of TNF-α, Fas/Fas ligand system and NT-proBNP in the early detection of asymptomatic left ventricular dysfunction in cancer patients treated with anthracyclines
22. Hybrid Coronary Revascularization: Promising, But Yet to Take Off
23. Genetic variations in the alanine–glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis
24. Subclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction
25. Poster No. 020 Increasing transvalvular gradient related to effectiveness of endogenous fibrinolysis in patients with severe aortic stenosis
26. 5-Year Follow-Up Images of a Balloon Expandable Valve Placed in Descending Aorta
27. The role of intravascular ultrasound and quantitative angiography in the functional assessment of intermediate coronary lesions: Correlation with fractional flow reserve
28. Abstract 14169: Implications of Elevated Troponin on Time-to-Surgery in Non-ST Elevation Myocardial Infarction (NIHR Health Informatics Collaborative: Trop-CABG Study)
29. Early Outcomes With Direct Flow Medical Versus First-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis
30. Clinical Outcomes of Real-World Patients Treated With an Amphilimus Polymer-Free Stent Versus New Generation Everolimus-Eluting Stents
31. Coronary artery bypass confers intermediate-term survival benefit over percutaneous coronary intervention with new-generation stents in real-world patients with multivessel coronary artery disease, including left main disease: a retrospective analysis of 6383 patients
32. Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt–chromium alloy stents in real-world diabetic patients
33. Early detection of subclinical left ventricular myocardial dysfunction in patients with chronic kidney disease
34. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New-Tokyo (MITO) registry
35. Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors
36. Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis:Insights from the WIN-TAVI registry
37. Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation
38. INTERVENTIONAL CARDIOLOGY: Outcomes in coronary stent trials—1 year is not enough
39. Is “the bigger the better” still valid for drug-eluting stents?
40. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden
41. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis
42. Iatrogenic Communications Between Aortic Root and Right Ventricle/Left Atrium After Transcatheter Aortic Valve Replacement
43. Pocket-size hand-held cardiac ultrasound as an adjunct to clinical examination in the hands of medical students and junior doctors
44. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?
45. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin
46. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis
47. Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?
48. The relationship of systemic right ventricular function to ECG parameters and NT-proBNP levels in adults with transposition of the great arteries late after Senning or Mustard surgery
49. Percutaneous Impella CP exchange with preservation of transfemoral access
50. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.